GL1X · GenesisL1 explorer

MolNFT v1 · #183144 · protein

Crystal structure of mg-132 covalently bound to the main protease (3CLPRO/MPRO) of SARS-cov-2 in spacegroup P1 in absence of dtt.

7NG6 · 3C-like proteinase: “Crystal structure of mg-132 covalently bound to the main protease (3CLPRO/MPRO) of SARS-cov-2 in spacegroup…”. X-ray diffraction, 2 ligands (ALD, CL), 7 pockets (best druggability 0.77). MolNFT v1 #183144 on…

PDB
7NG6
Type
protein
Length
607 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
3C-like proteinase
EC
3.4.22.69
UniProt
P0DTD1
Ligands
ALD, CL
Pockets
7 · best druggability 0.77

Structure

x-ray diffraction · 2 distinct chains · 25% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A3C-like proteinase (EC 3.4.22.69)protein30225% helix, 30% strandP0DTD1
B3C-like proteinase (EC 3.4.22.69)protein30525% helix, 29% strandP0DTD1

Ligands and binding sites

  • ALD · N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2S)-1-hydroxy-4-methylpentan-2-yl]-L-leucinamide · ligand · 2 copies · chains A, B
  • CL · Chloride ion · ion · chains A, B
  • ACT · Acetate ion · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19870.770.7988CL
21710.530.7926ALD
31910.520.7830ALD
41700.440.7425empty
51550.430.7428empty

Interfaces

1 interface between chains.

  • A–B · 1535 Ų buried · 37 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 7NG6 · Crystal structure of MG-132 covalently bound to the main protease (3CLpro/Mpro) of… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.